Thermo Fisher Scientific's smaller rivals will soon get the chance to test their theory that focus can challenge diversity.

When Thermo and Fisher merge at the end of the year, they will create a life sciences behemoth with $9 billion in annual revenues, 7,500 sales people, and 350,000 customers worldwide. The $10.6 billion deal is the biggest in the life-science tool segment on record; the next-biggest in size is GE Healthcare's $9.5 billion acquisition of Amersham in 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.